title: 25-hydroxyvitamin D status does not affect the clinical rituximab response in rheumatoid arthritis.
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Rim Ben
authors.initials: RB
authors.lastname: M'Barek
authors.affiliation: Biochemistry, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Dupré
authors.affiliation: Département d'Epidémiologie et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France; Inserm, CIE801 Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Tubach
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Dieudé
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Palazzo
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Hayem
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Karen
authors.initials: K
authors.lastname: Dawidowicz
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Ottaviani
authors.affiliation: Département d'Epidémiologie et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France; Inserm, CIE801 Paris, France.
authors.forename: Tony
authors.initials: T
authors.lastname: Alfaiate
authors.affiliation: Biochemistry, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Leçon-Malais
authors.affiliation: Biochemistry, AP-HP, Hôpital Bichat, Paris, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Boutten
authors.affiliation: Rheumatology, AP-HP, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France. Electronic address: olivier.meyer@bch.aphp.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Meyer
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D000069283:Rituximab; D016896:Treatment Outcome; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D014807:Vitamin D; D000069283:Rituximab; C104450:25-hydroxyvitamin D
keywords: Rheumatoid arthritis; Rituximab; Vitamin D